Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

9.6K
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
9.6K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Overview of the Vascular System01:20

Overview of the Vascular System

3.7K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
3.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sepsis-triggered proteolysis of profibrinolytic annexin A2 associated with microvasculopathy-related organ dysfunction.

Blood vessels, thrombosis & hemostasis·2026
Same author

Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.

Nature communications·2024
Same author

Blockade of Annexin A2 Prevents Early Microvasculopathy in Murine Models of Diabetic Retinopathy.

Investigative ophthalmology & visual science·2023
Same author

Annexin A2 Loss After Cardiopulmonary Bypass and Development of Acute Postoperative Respiratory Dysfunction in Children.

Critical care explorations·2023
Same author

Lipofuscin causes atypical necroptosis through lysosomal membrane permeabilization.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

Annexin A2 in Fibrinolysis, Inflammation and Fibrosis.

International journal of molecular sciences·2021

Related Experiment Video

Updated: Mar 18, 2026

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.8K

The annexin A2 system and angiogenesis.

Wei Liu, Katherine A Hajjar

    Biological Chemistry
    |July 2, 2016
    PubMed
    Summary

    The annexin A2 (ANXA2) complex promotes new blood vessel growth (angiogenesis) by aiding fibrinolysis. ANXA2-deficient mice studies reveal its crucial role in vivo, offering therapeutic potential.

    Area of Science:

    • Molecular Biology
    • Vascular Biology
    • Biochemistry

    Background:

    • Angiogenesis, the formation of new blood vessels, is tightly controlled by signaling molecules.
    • The annexin A2 (ANXA2) complex acts as an endothelial cell co-receptor, accelerating plasmin generation and fibrinolysis.
    • Plasmin activates matrix metalloproteinases, contributing to blood vessel patency and angiogenesis.

    Purpose of the Study:

    • To elucidate the pro-angiogenic role of the ANXA2 complex in vivo.
    • To detail the mechanisms by which ANXA2 regulates retinal and corneal angiogenesis.
    • To explore the therapeutic potential of ANXA2-interacting agents in angiogenesis-related disorders.

    Main Methods:

    • Generation and study of ANXA2-deficient mice.
    • In vivo investigations of ANXA2's role in angiogenesis.

    More Related Videos

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
    09:03

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

    Published on: November 23, 2014

    10.2K
    Aortic Ring Assay
    09:12

    Aortic Ring Assay

    Published on: November 24, 2009

    32.3K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
    09:03

    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

    Published on: June 30, 2023

    1.8K
    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
    09:03

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

    Published on: November 23, 2014

    10.2K
    Aortic Ring Assay
    09:12

    Aortic Ring Assay

    Published on: November 24, 2009

    32.3K
  • Analysis of ANXA2-interacting agents.
  • Main Results:

    • ANXA2 deficiency impairs angiogenesis in vivo.
    • ANXA2 complex promotes angiogenesis through pro-fibrinolytic activity.
    • ANXA2 supports angiogenesis in tumor-related settings and ocular models.

    Conclusions:

    • The ANXA2 complex plays a significant pro-angiogenic role.
    • Understanding ANXA2's molecular mechanisms is critical for therapeutic development.
    • ANXA2-centered pharmaceuticals show promise for treating angiogenesis-related disorders.